Trial Profile
Abilify (Aripiprazole) as an Adjunctive Treatment for Refractory Unipolar Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2015
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 05 Jun 2007 Status changed from recruiting to completed
- 26 Nov 2005 New trial record.